Related Experiment Video
Updated: Jul 14, 2026
09:29
Analysis of Nonhomologous End Joining and Homologous Recombination Efficiency in HEK-293T Cells Using GFP-Based Reporter Systems
Published on: February 2, 2024
Non-homologous DNA end joining in anticancer therapy
Elzbieta Pastwa1, Mariusz Malinowski
1Molecular Genetics Department, Medical University of Lodz, Lodz, Poland. epastwa@csk.umed.lodz.pl
Current Cancer Drug Targets
|May 17, 2007
Summary
Non-homologous DNA end joining (NHEJ) repairs DNA breaks in human cells. Inhibiting NHEJ offers new strategies to sensitize cancer cells to radiation and chemotherapy.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Non-homologous DNA end joining (NHEJ) is the primary mechanism for repairing DNA double-strand breaks (DSBs) in human cells.
- Key proteins within the NHEJ pathway represent potential molecular targets for cancer treatment.
- Targeting NHEJ can enhance the effectiveness of existing cancer therapies.
Purpose of the Study:
- To review novel therapeutic strategies aimed at inhibiting the NHEJ pathway.
- To explore the application of NHEJ inhibition in the context of anticancer therapy.
Main Methods:
- Literature review of current research on NHEJ inhibitors.
- Analysis of preclinical and clinical studies investigating NHEJ inhibition in cancer.
Main Results:
- Identification of emerging therapeutic strategies targeting NHEJ proteins.
- Evidence suggesting that NHEJ inhibition sensitizes cancer cells to radio- and chemotherapy.
Conclusions:
- Inhibition of the NHEJ pathway presents a promising approach for improving cancer treatment outcomes.
- Further research into NHEJ-targeted therapies could lead to more effective anticancer strategies.
Related Concept Videos
02:31Homologous Recombination
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
02:31Homologous Recombination
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:04Fixing Double-strand Breaks
The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
02:04Fixing Double-strand Breaks
The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...